Highlands Oncology Group Voted Best of Best By Readers’ Poll
Highlands Oncology Group, Northwest Arkansas’ leading cancer treatment group, was recently voted the “Best of the Best” in the oncology category by the Arkansas Democrat-Gazette’s annual readers’ poll. The winners of the Best of the Best Competition are selected by Arkansas Democrat-Gazette readers and members of the community.
Highlands Oncology Group offers cutting-edge technology and conducts clinical trials at the cusp of innovation. The cancer research and treatment group provides advanced technologies such as stereotactic body radiation therapy and Y90 radio immunization for liver cancer. Highlands Oncology Group was recently recognized at the second annual Clinical and Research Excellence (CARE) Awards for their use of IBM Watson to electronically screen patients for qualifying clinical trials.
Highlands Oncology Group is also a part of the Center for Chest Care and the Northwest Arkansas Lung Cancer Screening Program which provides free lung cancer screenings to high-risk individuals in the Northwest Arkansas community. The Northwest Arkansas Lung Cancer Screening Program is the only program of its kind in Arkansas certified by the Lung Cancer Alliance and the only non-hospital program certified nationwide. Additionally, they are part of the Arkansas Breast Cancer Specialists.
As the leading cancer treatment and research facility in Northwest Arkansas, Highlands Oncology Group is dedicated to the advancement of cancer treatment and to providing patients with the best possible care and results.
Highlands Oncology Group would like to thank the community for the honor and looks forward to continually serving Northwest Arkansas residents with care and dedication.